Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection
NCT04090346Phase 4Completed
- Sponsor
- Methodist Health System
- Start
- Jun 2018
- Primary completion
- Mar 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of fecal microbiome transplant in Clostridium difficile infection (CDI), sponsored by Methodist Health System. Started Jun 2018; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT04090346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04090346.